FibermarX Radiopaque Tissue Marker— 510(k) K190155

Name: FDA 510(k) clearance K190155
Creator: U.S. Food and Drug Administration
Published: 2019-02-27

Substantially Equivalent

Viscus Biologics, LLC

FDA 510(k) clearance K190155 for FibermarX Radiopaque Tissue Marker, Substantially Equivalent on 2019-02-27. Applicant: Viscus Biologics, LLC. Device class: 2.

Clearance details

Applicant: Viscus Biologics, LLC
Product code: Code IYE
Device class: Class 2
Regulation: 21 CFR 892.5050
Advisory panel: Radiology
Date received: 2019-01-30
Decision date: 2019-02-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cleveland, OH, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code IYE

view all

K261718 — EZFluence (RADEZ V2)2026-08-31
K260733 — MRIA Radiation Therapy Information System (MRIA)2026-08-26
K261856 — Halcyon, Ethos Radiotherapy System (5.0)2026-08-03
K252937 — ThinkQA 32026-06-12
K253004 — LUNA 3D2026-06-04

More clearances from Viscus Biologics, LLC

view all

K170026 — Radiopaque Tissue Marker2017-06-02
K140820 — XENOMEM WOUND MATRIX2015-06-26

Adverse events under product code IYE

product code IYE

Malfunction: 455
Other: 3
Total: 458

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.